[
  {
    "info": {
      "NCT": "NCT04488003",
      "Protocol_No": "BVD-523-ABC",
      "jit": "Not JIT",
      "trial_name": "BioMed Valley Discoveries BVD-523-ABC"
    },
    "disease": {
      "summary": "Advanced Solid Tumor | Colorectal Cancer CRC | Non Small Cell Lung | Melanoma | Head and Neck | Brain",
      "details": [
        {
          "code": "CNS/Brain (BRAIN)",
          "selection": "include",
          "stage": "Advanced Stage"
        },
        {
          "code": "Colorectal Adenocarcinoma (COADREAD)",
          "selection": "include",
          "stage": "Advanced Stage"
        },
        {
          "code": "Head and Neck (HEAD_NECK)",
          "selection": "include",
          "stage": "Advanced Stage"
        },
        {
          "code": "Melanoma (MEL)",
          "selection": "include",
          "stage": "Advanced Stage"
        },
        {
          "code": "Non-Small Cell Lung Cancer (NSCLC)",
          "selection": "include",
          "stage": "Advanced Stage"
        },
        {
          "code": "Solid Tumors",
          "selection": "include",
          "stage": "Advanced Stage"
        }
      ]
    },
    "query": {
      "nct": "NCT04488003",
      "title": "Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations",
      "current_status": "Not Recruiting",
      "status_verif_date": "August 2022",
      "last_update_date": "August 1, 2022",
      "trial_hold_status": "closed",
      "sponsor": "BioMed Valley Discoveries, Inc",
      "brief_summary": "This BVD-523-ABC study builds on the safety and clinical activity experience of previous studies that have evaluated ulixertinib as a novel targeted cancer treatment in cohorts of patients with specific genetic alterations and tumor histologies that result in aberrant MAPK pathway signaling. Early clinical data have demonstrated anti-tumor activity with ulixertinib treatment and have identified specific groups of patients for whom additional development is warranted.",
      "conditions": "Advanced Solid Tumor | BRAF Gene Mutation | BRAF Gene Alteration | MEK Mutation | MEK Alteration | MAP2K1 Gene Mutation | MAP2K1 Gene Alteration | MAP2K2 Gene Mutation | MAP2K2 Gene Alteration",
      "type": "Interventional",
      "phase": "Phase 2",
      "arm": [
        {
          "ArmID": "1",
          "cohortlabel": "Part A: Ulixertinib",
          "drug": "Ulixertinib",
          "arm_type": "Experimental",
          "line_of_therapy": "1;2;3+",
          "arm_hold_status": "closed",
          "biomarker": [
            {
              "cohort": "Part A: Ulixertinib",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "G469",
              "Selection": "include",
              "Function": "Not available",
              "summary": "BRAF G469 Alteration  "
            },
            {
              "cohort": "Part A: Ulixertinib",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "L485",
              "Selection": "include",
              "Function": "Not available",
              "summary": "BRAF L485 Alteration  "
            },
            {
              "cohort": "Part A: Ulixertinib",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "L597",
              "Selection": "include",
              "Function": "Not available",
              "summary": "BRAF L597 Alteration  "
            },
            {
              "cohort": "Part A: Ulixertinib",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Class II Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "BRAF Class II Mutation  "
            },
            {
              "cohort": "Part A: Ulixertinib",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "non-V600",
              "Selection": "include",
              "Function": "Not available",
              "summary": "BRAF non-V600 Alteration  "
            },
            {
              "cohort": "Part A: Ulixertinib",
              "Gene": "MEK1",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "MEK1 Alteration  "
            },
            {
              "cohort": "Part A: Ulixertinib",
              "Gene": "MEK2",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "MEK2 Alteration  "
            },
            {
              "cohort": "Part A: Ulixertinib",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "BRAF Alteration  "
            },
            {
              "cohort": "Part A: Ulixertinib",
              "Gene": "MAP2K1",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "MAP2K1 Alteration  "
            },
            {
              "cohort": "Part A: Ulixertinib",
              "Gene": "MAP2K2",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "MAP2K2 Alteration  "
            }
          ]
        },
        {
          "ArmID": "2",
          "cohortlabel": "Part B: Ulixertinib",
          "drug": "Ulixertinib",
          "arm_type": "Experimental",
          "line_of_therapy": "1;2;3+",
          "arm_hold_status": "closed",
          "biomarker": [
            {
              "cohort": "Part B: Ulixertinib",
              "Gene": "MEK1",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "MEK1 Alteration  "
            },
            {
              "cohort": "Part B: Ulixertinib",
              "Gene": "MEK2",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "MEK2 Alteration  "
            },
            {
              "cohort": "Part B: Ulixertinib",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "BRAF Alteration  "
            },
            {
              "cohort": "Part B: Ulixertinib",
              "Gene": "MAP2K1",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "MAP2K1 Alteration  "
            },
            {
              "cohort": "Part B: Ulixertinib",
              "Gene": "MAP2K2",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "MAP2K2 Alteration  "
            }
          ]
        },
        {
          "ArmID": "3",
          "cohortlabel": "Part B: Physician's choice of treatment",
          "drug": "Physician's Choice",
          "arm_type": "Experimental",
          "line_of_therapy": "1;2;3+",
          "arm_hold_status": "closed",
          "biomarker": [
            {
              "cohort": "Part B: Physician's choice of treatment",
              "Gene": "MEK1",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "MEK1 Alteration  "
            },
            {
              "cohort": "Part B: Physician's choice of treatment",
              "Gene": "MEK2",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "MEK2 Alteration  "
            },
            {
              "cohort": "Part B: Physician's choice of treatment",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "BRAF Alteration  "
            },
            {
              "cohort": "Part B: Physician's choice of treatment",
              "Gene": "MAP2K1",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "MAP2K1 Alteration  "
            },
            {
              "cohort": "Part B: Physician's choice of treatment",
              "Gene": "MAP2K2",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "MAP2K2 Alteration  "
            }
          ]
        }
      ],
      "docs": "<a href=\"https://trialplus.carisls.com/\" target=\"_blank\">Caris<\/a>",
      "locations": "Sioux Falls SD",
      "doclastupdate": "2023-01-30",
      "min_age": "18 Years",
      "gender": "All",
      "link": "<a href=\"https://clinicaltrials.gov/ct2/show/NCT04488003\" target=\"_blank\">NCT04488003<\/a>"
    }
  }
]
